|
|
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received for publication September 29, 2005.
Revised December 14, 2005.
Accepted for publication December 21, 2005.
We previously described the cDNA cloning of three functional rat histamine H3 receptor (rH3R) isoforms as well as the differential brain expression patterns of their corresponding mRNAs and signalling properties of the resulting rH3A, rH3B, and rH3C receptor isoforms (Drutel et al. (2001) Mol Pharmacol. 59:1-8). Herein we describe the cDNA cloning, mRNA localisation in the rat CNS and a pharmacological characterisation of three additional rH3R splice variants (rH3D-F) that differ from the previously published isoforms in that they result from an additional alternative-splicing event. These new H3R isoforms lack the seventh transmembrane (TM) helix and contain an alternative, putatively extracellular, C-terminus (6TM-rH3 isoforms). After heterologous expression in COS-7 cells, radioligand binding or functional responses upon the application of various H3R ligands could not be detected for the 6TM-rH3 isoforms. In contrast to the rH3A receptor (rH3AR), detection of the rH3D isoform using HA-antibodies revealed that the rH3D isoform remains mainly intracellular. The expression of the rH3D-F splice variants, however, modulates the cell surface expression-levels and subsequent functional responses of the 7TM-H3R isoforms. Co-expression of the rH3AR and the rH3D isoforms resulted in the intracellular retention of the rH3AR and reduced rH3AR functionality. Finally, we show that in rat brain the H3R mRNA expression levels are modulated upon treatment with the convulsant pentylenetetrazole, suggesting that the herein described rH3R isoforms thus represent a novel physiological mechanism for controlling the activity of the histaminergic system.
Key words:
Histamine, Gi family, Alternative splicing/RNA editing, Receptor synthesis/trafficking
This article has been cited by other articles:
![]() |
H. L. Haas, O. A. Sergeeva, and O. Selbach Histamine in the Nervous System Physiol Rev, July 1, 2008; 88(3): 1183 - 1241. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. van Rijn, P. L. Chazot, F. C. Shenton, K. Sansuk, R. A. Bakker, and R. Leurs Oligomerization of Recombinant and Endogenously Expressed Human Histamine H4 Receptors Mol. Pharmacol., August 1, 2006; 70(2): 604 - 615. [Abstract] [Full Text] [PDF] |
||||